Jeffrey Leiden
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2009-01-01–present
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Executive Chairman | — | $6,595,282 |
| 2022 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Executive Chairman | — | $8,593,180 |
| 2021 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Executive Chairman | $242,308 | $8,157,239 |
| 2020 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Executive Chairman | $1,121,539 | $16,473,245 |
| 2019 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Executive Chairman | $1,300,000 | $18,789,985 |
| 2018 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Executive Chairman (CEO and President through March 31, 2020) | $1,300,000 | $18,799,147 |
| 2017 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Executive Chairman (CEO and President through March 31, 2020) | $1,300,000 | $17,227,301 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.